Literature DB >> 21644086

Evaluation of agar films in the prevention of postoperative peritoneal adhesions in an animal model.

Mohsen Mamoudieh1, Nooshin Mirkheshti, Sayyed Ali Alavi.   

Abstract

BACKGROUND: Peritoneal adhesions cause significant long-term postoperative morbidity. This study evaluates the efficacy of agar plates as the physical barrier in reducing adhesion formation after abdominal surgery in an animal model.
METHODS: Adhesions were induced, by cecum abrasion, in 20 C57/BL6 mice during a laparotomy procedure. Agar plates were used in 10 mice as the experimental group. At a second operation, 28 days later, the adhesions were graded, in two groups. Data were analyzed by using Student t test.
RESULTS: There was no significant difference in weight gain of the two groups during the study period. A comparison of the morphological appearances of the adhesions demonstrated that there was no evident difference between the two groups. There was also no significant difference in the incidence ratio of adhesions or postoperative adhesion scores between the two groups (p value >0.05).
CONCLUSION: Despite the hydrogel properties of agar, it was not successful in practice in the reduction of adhesion formation after peritoneal surgery. Since agar is a biological product, it may cause a hyperreactivity induced by the innate immune system in peritoneum. Therefore, agar does not appear to be useful in clinical practice for the reduction of adhesion formation after peritoneal surgery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21644086     DOI: 10.5505/tjtes.2011.15689

Source DB:  PubMed          Journal:  Ulus Travma Acil Cerrahi Derg


  1 in total

1.  Preliminary study with SprayShield™ Adhesion Barrier System in the prevention of abdominal adhesions.

Authors:  Tomasz Banasiewicz; Karolina Horbacka; Jacek Karoń; Stanisław Malinger; Frantisek Antos; Sławomir Rudzki; Zdenek Kala; Zoran Stojcev; Jyrki Kössi; Piotr Krokowicz
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2013-05-06       Impact factor: 1.195

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.